Newborn affected by maternal use of unspecified medication
ICD-10 P04.19 is a billable code used to indicate a diagnosis of newborn affected by maternal use of unspecified medication.
P04.19 refers to newborns who are affected by maternal use of unspecified medications, which can include a range of substances such as drugs, alcohol, and tobacco that are transmitted through the placenta or breast milk. Maternal substance use can lead to various complications in newborns, including withdrawal symptoms, developmental delays, and other health issues. The impact of these substances can vary widely depending on the type and amount of substance used, as well as the timing of exposure during pregnancy. Common effects may include low birth weight, respiratory distress, and neurological impairments. It is crucial for healthcare providers to document maternal substance use accurately to ensure appropriate care and management of the newborn. This code is essential for capturing the complexities of maternal health behaviors and their direct impact on neonatal outcomes.
Detailed maternal history, including substance use, prenatal care records, and newborn assessment findings.
Newborns presenting with withdrawal symptoms, respiratory distress, or developmental delays due to maternal substance use.
Consider the timing of substance exposure and its potential effects on neonatal health; ensure thorough documentation of all findings.
Comprehensive pediatric evaluations that include maternal history and any observed effects on the newborn.
Pediatric follow-ups for newborns with developmental concerns linked to maternal substance use.
Monitor for long-term developmental outcomes and ensure continuity of care with appropriate referrals.
Used for newborns affected by maternal substance use requiring initial evaluation.
Document maternal history, newborn assessment, and any interventions.
Neonatologists should ensure comprehensive evaluations are performed.
Documentation should include a detailed maternal history of substance use, any observed effects on the newborn, and a comprehensive assessment of the newborn's health status.
